|
Since its establishment in 2000, Microbio continues to develop new concepts and advanced biopharmaceutical technology for the improvement of human lives and for the goal of health promotion to create greater values for our customers and shareholders.
Microbio is dedicated to
developing patented products with added value that can
improve people's health. The company offers "New Botanical Drugs" that are effective and safe without side
effects, Health Supplements for preventing diseases
and adding nutrients, and supplies quality "Raw Materials"
to the various pharmaceutical plants. The company satisfies
customers' needs with superior product quality. In the
development of "New Botaincal Drugs", the product "MicrSoy-20"
is the first new Chinese herbal drugs in Taiwan approved
for phase III clinical trial to aid cancer
treatment; MBS-2 has been granted by US Patent as "Method for inhibiting 15-LOX (15-lipoxygenase) with fermented Glycine max extract":
its main function is to reduce the risk of atherosclerosis and
prevent the occurrence of cardiovascular diseases. In
terms of "Dietary Supplements", Microbio has developed
and produced, based on the latest scientific research,
nutritional products that meet customer demands of supplementing
nutrients, enhancing immunity, and maintaining
vitality and youth to satisfy present day people's need
for balanced nutrition and health maintenance.
By applying scientific and standardized pharmaceutical concepts corroborated through scientific methods, Microbio Co., Ltd. conducts strict safety study, CMC pharmaceutical quality control, and scientific validation of product efficacy. |



|